Form of Change in Control, Bonus and Severance AgreementAgreement • May 15th, 2003 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT made as of March 17, 2003 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Roger C. Stikeleather, of Doylestown, Pennsylvania (the “Executive”), an individual presently employed as the Vice President Sales and Marketing of the Company.
